$473.7 K

Alseres Pharmaceuticals Revenue FY, 2013
Alseres Pharmaceuticals Net income (FY, 2013)-941.5 K
Alseres Pharmaceuticals EBIT (FY, 2013)-564.7 K
Alseres Pharmaceuticals Cash, 31-Dec-2013114 K

Alseres Pharmaceuticals Funding

Summary Metrics

Founding Date

1972

Alseres Pharmaceuticals Income Statement

Annual

USDFY, 2013

Revenue

473.7k

General and administrative expense

1.4m

Operating expense total

1.4m

EBIT

(564.7k)

EBIT margin, %

(119%)

Interest expense

454.7k

Net Income

(941.5k)

Alseres Pharmaceuticals Balance Sheet

Annual

USDFY, 2013

Cash

114.0k

Inventories

3.7k

Current Assets

324.6k

Total Assets

385.5k

Accounts Payable

1.1m

Current Liabilities

1.6m

Additional Paid-in Capital

188.7m

Total Equity

(10.7m)

Financial Leverage

0 x

Alseres Pharmaceuticals Cash Flow

Annual

USDFY, 2013

Net Income

(941.5k)

Depreciation and Amortization

1.2k

Cash From Operating Activities

(1.7m)

Cash From Investing Activities

884.4k

Cash From Financing Activities

900.0k

Alseres Pharmaceuticals Employee Rating

00 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source